Analysis Medibio Ltd. (MDBIF)
6/1/2024
Analysis of Medibio Ltd. (MDBIF)
Medibio Ltd. (MDBIF) has been trading at a consistent price of 0.01750 over the past several days, with no significant changes in the opening, low, and high prices. The Relative Strength Index (RSI) indicator is low at 15.08026, indicating potential oversold conditions.Looking at the Moving Average Convergence Divergence (MACD) indicator, the MACD line is slightly below the signal line, with a positive MACD histogram. This suggests a potential bullish momentum building up.
In terms of moving averages, the Simple Moving Average (SMA) and the Weighted Moving Average (WMA) are both at 0.01750, while the Exponential Moving Average (EMA) is slightly higher at 0.01795. This indicates a relatively stable trend in the stock price.
Overall, based on the RSI, MACD, and moving averages, it seems that Medibio Ltd. may be in a consolidation phase with a potential for a bullish breakout in the near future. However, further analysis and monitoring of the stock's price movement are recommended to confirm this potential trend reversal.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows good returns on assets and equity.
Looking at stock statistics, the short ratio is low, and a significant portion of shares is held by institutions. The stock price has a beta of 1.264 and has shown a slight increase over the fifty-two week period.
Valuation metrics suggest that the stock may be overvalued based on the PEG ratio and price to book ratio. The company's market capitalization and enterprise value are substantial compared to its revenue and EBITDA.
The dividends and splits information shows that the company pays dividends, with a moderate dividend yield. The last split date was in August 2020.
Overall, the data provides a comprehensive overview of the company's financial health, stock performance, valuation, and dividend policy.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, the quarter ending on August 1, 2024, had an EPS estimate of 1.32.Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:- 2020: $274,515,000,000
- 2021: $365,817,000,000
- 2022: $394,328,000,000
- 2023: $383,285,000,000
From these numbers, we can observe the following trends:
1. There was a steady increase in revenue from 2020 to 2022, with a significant jump between 2021 and 2022.
2. However, in 2023, there was a slight decrease in revenue compared to the previous year.
3. Overall, the company has shown growth in revenue over the past four years, with some fluctuations in the most recent year.
These insights can help in analyzing the company's performance and making strategic decisions for the future.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets, resulting in a growth in shareholders' equity.
5. Shareholders' equity includes common stock and retained earnings, with fluctuations in other shareholders' equity components.
6. The company has been managing its short-term and long-term debts while investing in non-current assets for future growth.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant variability, with large amounts being spent on common stock repurchase and debt issuance.
6. Investing activities also vary, with significant amounts being spent on the sale and purchase of investments, as well as capital expenditures.
7. Net income has been relatively stable, with some fluctuations over the years.
8. Depreciation and stock-based compensation have been significant non-cash items impacting the cash flow.
9. Overall, the company's cash flow statement reflects a mix of stable and fluctuating financial activities over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This forecast suggests a slight improvement from the EPS of $6.10 in the current year.
Overall, the analysts' estimates show a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest a positive growth trend for the company, with a slight decrease in growth rate from the past 5 years to the next 5 years. However, the company is still expected to maintain a healthy growth rate in the upcoming periods.
Price target
The analysts' forecast for the future price of the security paper is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a wide range of opinions on the future price of the security paper, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating a potential opportunity for growth according to the analysts' predictions.
MACD of MDBIF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
